Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens

Roland Houben1, Masahiro Shuda, Rita Weinkam

  • 1Molecular Virology Program, University of Pittsburgh Cancer Institute, 5117 Centre Ave., Pittsburgh, PA 15213, USA.

Insights

Human Merkel cell polyomavirus (MCV) T-antigen (TA) is essential for maintaining Merkel cell carcinoma (MCC) growth. Knocking down MCV TA expression caused MCC cell death, confirming MCV as the infectious cause of MCC.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Merkel cell carcinoma (MCC) is an aggressive skin cancer.
  • Human Merkel cell polyomavirus (MCV) is found in ~80% of MCC tumors.
  • The role of viral oncogenic proteins in MCC maintenance is unclear.

Purpose of the Study:

  • To determine if MCV T-antigen (TA) expression is required for MCC cell survival.
  • To investigate the oncogenic role of MCV in MCC.

Main Methods:

  • Knockdown of MCV T-antigen (TA) in MCC cell lines using shRNA vectors.
  • Utilized MCV-positive and MCV-negative MCC cell lines.
  • Assessed cell growth, cell death markers (annexin V, 7-AAD), and apoptosis-related proteins (caspases, Bcl-2 family).

Main Results:

  • MCV-positive MCC cell lines showed growth arrest and/or cell death after TA knockdown.
  • MCV-negative cell lines were unaffected by TA knockdown.
  • Apoptosis markers were elevated, but caspase activation and Bcl-2 family changes were inconsistent.

Conclusions:

  • MCV T-antigen expression is necessary for the maintenance of MCV-positive MCC cells.
  • Provides direct evidence that MCV is the infectious agent causing MCV-positive MCC.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...